Bamboos Health Care Holdings Limited (2293.HK)
HKD 0.66
(0.0%)
HKD 0.66
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 37.41 Million | 41.93 Million | 116.11 Million | 49.43 Million | 45.51 Million | 31.96 Million |
| Net Income | 39.22 Million | 46.91 Million | 58.62 Million | 61.02 Million | 30.69 Million | 47.11 Million |
| Depreciation & Amortization | 10.13 Million | 9.99 Million | 7.68 Million | 4.36 Million | 5.8 Million | 875 Thousand |
| Deferred income taxes | - | 266 Thousand | -18.47 Million | 38.46 Million | -548 Thousand | -8.83 Million |
| Stock-based compensation | 568 Thousand | 18 Thousand | 2.64 Million | 2.64 Million | 2.53 Million | 549 Thousand |
| Change in working capital | -3.52 Million | -284 Thousand | 17.72 Million | -41.1 Million | 11.55 Million | -6.9 Million |
| Other non-cash items | -8.42 Million | -14.97 Million | 49.8 Million | -15.94 Million | -4.52 Million | -843 Thousand |
| Investing Cash Flow | -7.09 Million | 6.91 Million | -111.63 Million | -71.37 Million | -29.71 Million | -70 Thousand |
| Investments in PPE | -1.66 Million | -261 Thousand | -15.74 Million | -22 Thousand | -2.62 Million | -214 Thousand |
| Acquisitions | - | -5.21 Million | 303 Thousand | -2000.00 | 3000.00 | -1.14 Million |
| Investment purchases | -9.78 Million | -3.56 Million | -85.98 Million | -85.98 Million | -38.06 Million | - |
| Sales/Maturities of investments | 2.48 Million | 8.78 Million | 70.67 Million | 10.6 Million | 10.96 Million | - |
| Other Investing Activities | 1.87 Million | 7.17 Million | -80.88 Million | 4.02 Million | -26.05 Million | 1.29 Million |
| Financing Cash Flow | -42.44 Million | -41.79 Million | 25.15 Million | -23.04 Million | -32.87 Million | -10 Million |
| Debt repayment | -2.4 Million | -4.98 Million | -27.17 Million | -3.04 Million | -2.87 Million | - |
| Dividends payments | -35.12 Million | -35 Million | -40 Million | -20 Million | -30 Million | -10 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -4.91 Million | -1.81 Million | 62.32 Million | -2000.00 | 3000.00 | - |
| Accounts receivables | 7.36 Million | -1.51 Million | 20.75 Million | -41.27 Million | 17.18 Million | 2.79 Million |
| Accounts payables | -16.2 Million | -8.33 Million | 19.16 Million | 15.02 Million | -3.6 Million | -2.04 Million |
| Inventory | 758 Thousand | 1.23 Million | -3.02 Million | 164 Thousand | 17 Thousand | -48 Thousand |
| Other working capital | -11.64 Million | 8.33 Million | -19.16 Million | -15.02 Million | -2.04 Million | -7.61 Million |
| Cash at beginning of period | 93.26 Million | 86.26 Million | 56.65 Million | 101.63 Million | 118.7 Million | 96.8 Million |
| Cash at end of period | 81.14 Million | 93.26 Million | 86.26 Million | 56.65 Million | 101.63 Million | 118.7 Million |
| Capital Expenditure | -1.66 Million | -261 Thousand | -15.74 Million | -22 Thousand | -2.62 Million | -214 Thousand |
| Effect of forex changes on cash | -6000.00 | -55 Thousand | -15 Thousand | 2000.00 | -3000.00 | - |
| Net cash flow / Change in cash | -12.12 Million | 7 Million | 29.61 Million | -44.98 Million | -17.07 Million | 21.89 Million |
| Free Cash Flow | 35.75 Million | 41.67 Million | 100.36 Million | 49.41 Million | 42.89 Million | 31.75 Million |
| Breakdown | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 | 2021 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 13.79 Million | 17.12 Million | 46.91 Million | 16.33 Million | 30.58 Million | 25.12 Million |
| Depreciation & Amortization | - | 4.91 Million | 9.99 Million | 4.28 Million | 5.7 Million | 5.22 Million |
| Deferred income taxes | - | - | 266 Thousand | 145 Thousand | - | -9.14 Million |
| Stock-based compensation | 534 Thousand | 34 Thousand | 18 Thousand | -6000.00 | 24 Thousand | 569 Thousand |
| Change in working capital | - | - | -284 Thousand | -54 Thousand | - | 19.05 Million |
| Other non-cash items | -14.33 Million | -22.56 Million | -14.97 Million | 15.44 Million | -30.38 Million | 30.5 Million |
| Investing Cash Flow | - | -1.83 Million | 6.91 Million | 3.78 Million | 3.12 Million | 11.42 Million |
| Investments in PPE | - | - | -261 Thousand | -261 Thousand | -48 Thousand | -15.74 Million |
| Acquisitions | - | - | -5.21 Million | - | - | - |
| Investment purchases | - | - | -3.56 Million | - | - | - |
| Sales/Maturities of investments | - | - | 8.78 Million | - | - | - |
| Other Investing Activities | - | -1.83 Million | 7.17 Million | 4.05 Million | 3.12 Million | 31.23 Million |
| Financing Cash Flow | - | -16.21 Million | -41.79 Million | -19.51 Million | -22.28 Million | -27.71 Million |
| Debt repayment | - | - | -4.98 Million | - | - | -68.23 Million |
| Dividends payments | - | -15 Million | -35 Million | -15 Million | -20 Million | -40 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -1.21 Million | -1.81 Million | -4.51 Million | -2.28 Million | 71.6 Million |
| Accounts receivables | - | - | -1.51 Million | -1.51 Million | - | 20.75 Million |
| Accounts payables | - | - | -8.33 Million | - | - | - |
| Inventory | - | - | 1.23 Million | 1.23 Million | - | -3.02 Million |
| Other working capital | - | - | 8.33 Million | 230 Thousand | - | 1.32 Million |
| Cash at beginning of period | 74.72 Million | 93.26 Million | 86.26 Million | 73.01 Million | 86.26 Million | 52.14 Million |
| Cash at end of period | 74.72 Million | 74.72 Million | 93.26 Million | 93.26 Million | 73.01 Million | 86.26 Million |
| Capital Expenditure | - | - | -261 Thousand | -261 Thousand | -48 Thousand | -15.74 Million |
| Effect of forex changes on cash | - | 2000.00 | -55 Thousand | -35 Thousand | -20 Thousand | 12 Thousand |
| Net cash flow / Change in cash | - | -18.54 Million | 7 Million | 20.25 Million | -13.24 Million | 34.12 Million |
| Free Cash Flow | - | -501 Thousand | 41.67 Million | 35.75 Million | 5.87 Million | 34.66 Million |
9531
CLBR
5440
HD
CFC
FCELB